Maria Jose Domper-Arnal
Overview
Explore the profile of Maria Jose Domper-Arnal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tejedor-Tejada J, Ballester M, Del Castillo-Corzo F, Garcia-Mateo S, Domper-Arnal M, Parada-Vazquez P, et al.
Eur J Gastroenterol Hepatol
. 2024 Sep;
37(1):15-23.
PMID: 39324889
Introduction: Patient blood management (PBM) adherence in clinical practice is unclear. This real-world practice study assessed the management of patients with gastrointestinal (GI) bleeding after the implementation of the PBM...
2.
Irun P, Carrera-Lasfuentes P, Sanchez-Luengo M, Belio U, Domper-Arnal M, Higuera G, et al.
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003333
Omega-3 polyunsaturated fatty acids (PUFAs) play a vital role in human health, well-being, and the management of inflammatory diseases. Insufficient intake of omega-3 is linked to disease development. Specialized pro-resolving...
3.
Espina S, Casas-Deza D, Bernal-Monterde V, Domper-Arnal M, Garcia-Mateo S, Lue A
Nutrients
. 2023 Aug;
15(15).
PMID: 37571424
Liver diseases are the major predisposing conditions for the development of malnutrition, sarcopenia, and frailty. Recently, the mechanism of the onset of these complications has been better established. Regardless of...
4.
Hermoso-Duran S, Domper-Arnal M, Roncales P, Vega S, Sanchez-Gracia O, Ojeda J, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046613
(1) Background: About 50% of prescribed colonoscopies report no pathological findings. A secondary screening test after fecal immunochemical test positivity (FIT+) would be required. Considering thermal liquid biopsy (TLB) as...
5.
Hijos-Mallada G, Alfaro E, Navarro M, Canamares P, Arino I, Charro M, et al.
Gastroenterol Hepatol
. 2023 Jan;
46(9):702-709.
PMID: 36716926
Background And Objective: The COVID-19 pandemic has been associated with a decrease in the colorectal cancer (CRC) incidence, due to the disruption of screening programmes and a downscaling of endoscopic...
6.
Cardenas-Jaen K, Sanchez-Luna S, Vaillo-Rocamora A, Castro-Zocchi M, Guberna-Blanco L, Useros-Branas D, et al.
Gastroenterol Hepatol
. 2022 Oct;
46(6):425-438.
PMID: 36243249
Background: Retrospective studies suggest that coronavirus disease (COVID-19) commonly involves gastrointestinal (GI) symptoms and complications. Our aim was to prospectively evaluate GI manifestations in patients hospitalized for COVID-19. Methods: This...
7.
Domper-Arnal M, Hijos-Mallada G, Lanas A
Therap Adv Gastroenterol
. 2022 Aug;
15:17562848221117636.
PMID: 36035306
The novel coronavirus disease 2019 (COVID-19) pandemic has posed an unprecedented challenge to healthcare systems worldwide, causing downscaling of almost all other activities, especially in its early stages. Currently, the...
8.
Martinez-Dominguez S, Lanas A, Domper-Arnal M
Med Clin (Barc)
. 2022 May;
159(2):92-100.
PMID: 35606193
The main clinical relevance of Barrett's esophagus (BE), a result of chronic exposure to gastroesophageal reflux, is its potential progression to esophageal adenocarcinoma (EAC). Although screening for BE is not...
9.
Ampuero J, Lucena A, Hernandez-Guerra M, Moreno-Moraleda I, Arenas J, Conde I, et al.
Gut
. 2021 Dec;
PMID: 34876479
No abstract available.